AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
175 hedge funds and large institutions have $2.94B invested in Aerie Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 73 increasing their positions, 55 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 172 → 175 (+3)
40% less call options, than puts
Call options by funds: $20.6M | Put options by funds: $34.6M
Holders
175
Holding in Top 10
10
Calls
$20.6M
Puts
$34.6M
Top Buyers
| 1 | +$24.7M | |
| 2 | +$22.2M | |
| 3 | +$17.6M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.8M |
| 5 |
BlackRock
New York
|
+$16.7M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$18.3M | |
| 3 | -$16.4M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$14.6M |
| 5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$14M |